Table 1Summary of the protocol (PICO table)

PopulationPregnant women with chronic hypertension. This population includes women with:
  • Essential (primary) hypertension
  • Secondary hypertension e.g. secondary to chronic kidney disease, diabetes.
Intervention
  • Centrally acting alpha2-adrenoceptor agonists
  • Beta-blockers/mixed alpha/beta-blockers
  • Calcium channel blockers
  • Diuretics
  • Angiotensin converting enzyme (ACE) inhibitors
  • Acetylsalicylic acid/aspirin
  • Elective (planned) delivery versus expectant management
  • Tight management (for example, diastolic target = 85mmHg)
  • Less-tight management (for example, diastolic target = 100 mmHg)
  • Automated monitoring of blood pressure
  • Ambulatory/self-monitoring of blood pressure
  • Exercise
  • Dietary interventions
  • Dietary salt reduction
Comparison
  • No intervention
  • Placebo
  • Each other of the interventions outlined above
  • Combinations of the interventions outlined above
Outcome

Outcomes for babies

Critical outcomes:

  • Perinatal mortality
    • Stillbirth (include if reported as part of perinatal mortality)
    • Neonatal death up to 7 days (include if reported as part of perinatal mortality)
  • Small-for-gestational age (birthweight <10th centile)
Important outcomes:
  • Birth weight
  • Gestational age at birth
  • Preterm birth (<28 weeks, <34 weeks, <37 weeks)
  • Admission to neonatal unit
  • Neurodevelopmental outcomes:
    • Cerebral palsy (CP) (dichotomous outcome, reported as present/absent, not severity of condition)
    • Neurodevelopmental delay (dichotomous outcome, not continuous outcomes such as mean change in score):
      -

      Severe (score of >2SD below normal on validated assessment scales, or Bayley assessment scale of mental development index [MDI] or psychomotor developmental index [PDI] <70, or complete inability to assign score due to CP or severe cognitive delay)

      -

      Moderate (score of 1-2 SD below normal on validated assessment scales, or Bayley assessment scale MDI or PDI 70-84)

    • Neurosensory impairment (dichotomous outcome, present or absent, not severity of condition)
      -

      Severe hearing impairment (for example, deaf)

      -

      Severe visual impairment (for example, blind)

Outcomes for women:

Critical outcomes:

  • Blood pressure control
    • Severe hypertension
Important outcomes:
  • Superimposed pre-eclampsia
    • including eclampsia and HELLP syndrome
  • Placental abruption
  • Onset of labour
  • Mode of birth
  • Maternal death

ACE: angiotensin converting enzyme; CP: cerebral palsy; HELLP: haemolysis, elevated liver enzymes, low platelets; MDI: mental development index; mmHg: millimetres of mercury; PDI: psychomotor developmental index; SD: standard deviation

From: Evidence review for interventions for chronic hypertension

Cover of Evidence review for interventions for chronic hypertension
Evidence review for interventions for chronic hypertension: Hypertension in pregnancy: diagnosis and management: Evidence review A.
NICE Guideline, No. 133.
National Guideline Alliance (UK).
Copyright © NICE 2019.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.